The impact of demographic, clinical, genetic, and imaging variables on tau PET status

被引：0
作者：
Rik Ossenkoppele
Antoine Leuzy
Hanna Cho
Carole H. Sudre
Olof Strandberg
Ruben Smith
Sebastian Palmqvist
Niklas Mattsson-Carlgren
Tomas Olsson
Jonas Jögi
Erik Stormrud
Young Hoon Ryu
Jae Yong Choi
Adam L. Boxer
Maria L. Gorno-Tempini
Bruce L. Miller
David Soleimani-Meigooni
Leonardo Iaccarino
Renaud La Joie
Edilio Borroni
Gregory Klein
Michael J. Pontecorvo
Michael D. Devous
Sylvia Villeneuve
Chul Hyoung Lyoo
Gil D. Rabinovici
Oskar Hansson
机构：
[1] Lund University,Clinical Memory Research Unit
[2] Vrije Universiteit Amsterdam,Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, VU University Medical Center
[3] Yonsei University College of Medicine,Department of Neurology, Gangnam Severance Hospital
[4] King’s College London,School of Biomedical Engineering and Imaging Sciences
[5] UCL Institute of Neurology,Dementia Research Centre, Department of Neurodegenerative Disease
[6] University College London,Centre for Medical Image Computing, Department of Medical Physics
[7] Skåne University Hospital,Department of Neurology
[8] Lund University,Wallenberg Centre for Molecular Medicine
[9] Skåne University Hospital,Department of Radiation Physics
[10] Skåne University Hospital,Department of Clinical Physiology and Nuclear Medicine
[11] Skåne University Hospital,Memory Clinic
[12] Yonsei University College of Medicine,Department of Nuclear Medicine, Gangnam Severance Hospital
[13] Korea Institute Radiological and Medical Sciences,Division of applied RI
[14] University of California San Francisco,Department of Neurology, Memory and Aging Center
[15] F. Hoffmann-La Roche Ltd,Departments of Psychiatry and Neurology & Neurosurgery, Douglas Mental Health University Institute
[16] Avid Radiopharmaceuticals,Department of Radiology and Biomedical Imaging
[17] McGill University,Molecular Biophysics and Integrated Bioimaging Division
[18] University of California San Francisco,undefined
[19] Lawrence Berkeley National Laboratory,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
PET; Tau; Aβ; Alzheimer’s disease; MCI; Dementia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2245 / 2258
页数：13
相关论文
共 238 条
  • [1] Selkoe DJ(1991)The molecular pathology of Alzheimer's disease Neuron. 6 487-498
  • [2] Leuzy A(2019)Tau PET imaging in neurodegenerative tauopathies-still a challenge Mol Psychiatry 24 1112-1134
  • [3] Chiotis K(2019)The bivariate distribution of amyloid-beta and tau: relationship with established neurocognitive clinical syndromes Brain. 142 3230-3242
  • [4] Lemoine L(2018)Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders JAMA. 320 1151-1162
  • [5] Gillberg PG(2017)Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition Brain. 140 748-763
  • [6] Almkvist O(2018)[(18)F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia J Neurol Neurosurg Psychiatry 89 1032-1037
  • [7] Rodriguez-Vieitez E(2017)(18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study Ann Neurol 82 622-634
  • [8] Jack CR(2019)Sex differences in the Association of Global Amyloid and Regional Tau Deposition Measured by positron emission tomography in clinically normal older adults JAMA Neurol 76 542-551
  • [9] Wiste HJ(2016)Tau PET in Alzheimer disease and mild cognitive impairment Neurology. 87 375-383
  • [10] Botha H(2019)White matter hyperintensities: relationship to amyloid and tau burden Brain. 142 2483-2491
12345678910